HR
CVS icon

Howe & Rusling’s CVS Health CVS Stock Holding History

Howe & Rusling’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,756
Closed -$219K – 483
2025
Q4 		$219K Sell
2,756
-127
-4% -$10K 0.01% 287
2025
Q3 		$217K Sell
2,883
-165
-5% -$11.3K 0.01% 280
2025
Q2 		$210K Buy
+3,048
New +$200K 0.02% 278
2024
Q2 		– Sell
-3,290
Closed -$262K – 369
2024
Q1 		$262K Buy
3,290
+80
+2% +$6.11K 0.03% 220
2023
Q4 		$253K Sell
3,210
-472
-13% -$33.6K 0.03% 204
2023
Q3 		$257K Sell
3,682
-30
-0.8% -$2.13K 0.03% 192
2023
Q2 		$257K Sell
3,712
-365
-9% -$26K 0.03% 199
2023
Q1 		$303K Sell
4,077
-397
-9% -$33.3K 0.04% 177
2022
Q4 		$417K Buy
4,474
+149
+3% +$14.4K 0.05% 137
2022
Q3 		$412K Buy
4,325
+1,337
+45% +$132K 0.05% 137
2022
Q2 		$277K Buy
2,988
+7
+0.2% +$683 0.04% 166
2022
Q1 		$302K Sell
2,981
-100
-3% -$10.5K 0.03% 165
2021
Q4 		$318K Hold
3,081
– – 0.04% 158
2021
Q3 		$261K Hold
3,081
– – 0.03% 174
2021
Q2 		$257K Buy
3,081
+241
+8% +$19.7K 0.03% 159
2021
Q1 		$214K Sell
2,840
-16
-0.6% -$1.17K 0.03% 169
2020
Q4 		$195K Sell
2,856
-2,879
-50% -$187K 0.03% 165
2020
Q3 		$335K Sell
5,735
-125,621
-96% -$7.82M 0.06% 117
2020
Q2 		$8.53M Buy
131,356
+14,915
+13% +$939K 1.57% 19
2020
Q1 		$6.91M Sell
116,441
-53,388
-31% -$3.56M 1.49% 22
2019
Q4 		$12.6M Sell
169,829
-72,483
-30% -$5.09M 2.09% 9
2019
Q3 		$15.3M Sell
242,312
-274
-0.1% -$16.2K 2.68% 3
2019
Q2 		$13.2M Buy
242,586
+48,039
+25% +$2.59M 2.28% 7
2019
Q1 		$10.5M Buy
194,547
+43,028
+28% +$2.66M 1.82% 13
2018
Q4 		$9.93M Sell
151,519
-11,892
-7% -$888K 2.1% 13
2018
Q3 		$12.9M Buy
163,411
+163,152
+62,993% +$11.7M 2.15% 13
2018
Q2 		$17K Buy
259
+100
+63% +$6.59K ﹤0.01% 374
2018
Q1 		$10K Sell
159
-1,811
-92% -$130K ﹤0.01% 497
2017
Q4 		$143K Hold
1,970
– – 0.03% 208
2017
Q3 		$160K Buy
1,970
+1,932
+5,084% +$153K 0.03% 191
2017
Q2 		$3K Sell
38
-870
-96% -$68.7K ﹤0.01% 710
2017
Q1 		$71K Sell
908
-910
-50% -$72.6K 0.01% 225
2016
Q4 		$143K Sell
1,818
-1,707
-48% -$138K 0.03% 169
2016
Q3 		$314K Sell
3,525
-108,889
-97% -$10.3M 0.07% 128
2016
Q2 		$10.8M Sell
112,414
-7,837
-7% -$781K 2.37% 5
2016
Q1 		$12.5M Buy
120,251
+7,819
+7% +$760K 2.81% 2
2015
Q4 		$11M Sell
112,432
-2,688
-2% -$263K 2.52% 3
2015
Q3 		$11.1M Buy
115,120
+1,524
+1% +$160K 2.76% 3
2015
Q2 		$11.9M Buy
113,596
+343
+0.3% +$35K 2.6% 3
2015
Q1 		$11.7M Buy
113,253
+4,236
+4% +$429K 2.62% 3
2014
Q4 		$10.5M Buy
109,017
+42,559
+64% +$3.75M 2.52% 4
2014
Q3 		$5.29M Buy
66,458
+3,857
+6% +$304K 1.23% 32
2014
Q2 		$4.72M Sell
62,601
-454
-0.7% -$34.3K 1.06% 36
2014
Q1 		$4.72M Buy
+63,055
New +$4.45M 1.16% 35
2013
Q4 		– Sell
-185
Closed -$11K – 823
2013
Q3 		$11K Buy
+185
New +$11K ﹤0.01% 579

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Howe & Rusling's CVS Position: Q1 2026 in Review

Howe & Rusling sold out of CVS Health (CVS) in Q1 2026, closing a stake of 2,756 shares — an estimated $219K sold.

Howe & Rusling first reported a position in CVS in Q3 2013 and held it in 45 quarters. The position peaked at $15.3M in Q3 2019. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Howe & Rusling reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Howe & Rusling sold 2,756 CVS Health shares in Q1 2026, an estimated $219K.
  • Howe & Rusling first reported a position in CVS Health in Q3 2013 and held it in 45 quarters.
  • Howe & Rusling's CVS Health position peaked at $15.3M in Q3 2019.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.